Shares of AngioDynamics (ANGO +2.4%) were roiled late in the trading day after the company cut...

Shares of AngioDynamics (ANGO+2.4%) were roiled late in the trading day after the company cut its FQ3 and FY revenue forecast and halted shipments of it NanoKnife ablation device in the U.S. due to a software recall. It now sees Q3 sales between $50M - $53M versus estimates of $53M, and 2012 sales of around $215M - $219M compared to expectations of $221M.